Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00313521Phase 2Unknown
Phase 2, open-label, single-arm trial of thiotepa in astrocytoma, sponsored by Children's Cancer and Leukaemia Group. Primary endpoints: Tumor response to adjuvant thiotepa followed by radiotherapy and Degree of surgical resection. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00313521.